Lack of evidence for expression of Fas ligand in Fas-bearing tumors

Oncology Reports

Volumn 5, Issue 2, 1998, Pages 377-380

  Takagi, Atsushi ^a   Imai, Atsushi ^a   Horibe, Shinji ^a   Ohno, Tsukasa ^a   Tamaya, Teruhiko ^a  

^a GIFU UNIVERSITY   (Japan)

Author keywords

Apoptosis; Fas; Fas ligand; Genital tumor

Indexed keywords

FAS ANTIGEN; LIGAND; MESSENGER RNA;

ANIMAL TISSUE; ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; CELL PROLIFERATION; ENDOMETRIUM CARCINOMA; FEMALE; LYMPHOCYTE; MESSENGER RNA SYNTHESIS; NONHUMAN; OVARY CARCINOMA; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 0031935325     PISSN: 1021335X     EISSN: None     Source Type: Journal    
DOI: 10.3892/or.5.2.377     Document Type: Article

References (20)

1. Nagata S and Golstein P: The Fas death factor. Science 267: 1449-1456, 1995.
2. Schwartzman R and Cidlowski J: Apoptosis: the biochemistry and molecular biology of programmed cell death. Endocrinol Rev 14: 133-151, 1993.
3. Imai A, Horibe S, Takagi A, Ohno T and Tamaya T: Frequent expression of Fas in gonadotropin-releasing hormone receptor-bearing tumors. Eur J Obstet Gynecol Reprod Biol 74: 73-78, 1997.
4. Fuseya T, Imai A, Horibe S, Takagi A, Ohno T and Tamaya T: Expression of Fas in female reproductive tract tumors. Oncol Rep 3: 1107-1109, 1996.
5. Griffith TS, Brunner T, Fletcher SM Green DR and Ferguson TA: Fas ligand-induced apoptosis as a mechanism of immune privilege. Science 270: 1189-1192, 1995.
6. Runic R, Lockwood CJ, Ma Y. Dipasquale B and Guller S: Expression of Fas ligand by human cytotrophoblasts: implications in placentation and fetal survival. J Clin Endocrinol Metab 81: 3119-3122, 1996.
7. Chomczynski P and Sacchi N: Single-step method of RNA isolation by acid suanidium thiocyanate-chloroform extraction. Anal Biochem 162: 156-159, 1987.
8. Ohno T, Imai A, Furui T, Takahashi K and Tamaya T: Presence of gonadotropin-releasing hormone and us messenger ribonucleic acid in human ovarian epithelial carcinoma. Am J Obstet Gynecol 169: 605-610, 1993.
9. Suda T, Takahashi T, Goldstein P and Nagata S: Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family. Cell 75: 1169-1178, 1993.
10. Toneguzzo F, Glynn S, Levi E, Mjolsness S and Hayday A: Use of a chemically modified T7 DNA polymerase for manual and automated sequencine of supercoiled DNA. Biotechniques 6: 460-469, 1988.
11. Imai A and Gershengom MC: independent phosphatidylinositol synthesis in rat pituitary plasma membrane and endoplasmic reticulum. Nature 325: 725-728, 1987.
12. Imai A and Gershensorn MC: Measurement of lipid turnover in response to TRH. Methods Enzymol 141: 100-111, 1987.
13. Lowry OH, Rosenbrough N, Farr AL and Randall RJ: Protein measurement with the Folin phenol reagent. J Biol Chem 193: 265-275, 1951.
14. Laemmli WK: Cleavage of structural proteins during the assembly of the head of bacteriophage lambda. Nature 227: 680-685, 1970.
15. Imai A, Takagi H, Horibe S, Fuseya T and Tamaya T: Coupling of gonadotropin-releasing hormone receptor to Gi protein in human reproductive tract tumors. J Clin Endocrinol Metab 81: 3249-3253, 1996.
16. Suda T and Nagata S: Purification and characterization of the Fasligand that induces apoptosis. J Exp Med 179: 873-880, 1994.
17. Imai A, Horibe S, Takagi H, Fuseya T and Tamaya T: Signal transduction of GnRH receptor in the reproductive tract tumor. Endocrinol J 43: 249-260, 1966.
18. Emons G and Schally AV: The use of luteinizing hormone releasing hormone agonists and antagonists in gynecological cancers. Hum Reprod Update 9: 1364-1379, 1994.
19. Imai A, Horibe S, Takagi A and Tamaya T: Gi protein activation of gonadotropin-releasing hormone-mediated protein dephosphorylation in human endometrial carcinoma. Am J Obstet Gynecol 176: 371-376, 1997.
20. Sato T, Irie S, Kitada S and Reed J: FAP-1: A protein tyrosine phosphatase that associates with Fas. Science 268: 411-415, 1995.